Automated Modular Synthesis of Aptamer–Drug Conjugates for Targeted Drug Delivery

Citations Over TimeTop 10% of 2014 papers

Abstract

Aptamer-drug conjugates (ApDCs) are promising targeted drug delivery systems for reducing toxicity while increasing the efficacy of chemotherapy. However, current ApDC technologies suffer from problems caused by the complicated preparation and low controllability of drug-aptamer conjugation. To solve such problems, we have designed and synthesized a therapeutic module for solid phase synthesis, which is a phosphoramdite containing an anticancer drug moiety and a photocleavable linker. Using this module, we have realized automated and modular synthesis of ApDCs, and multiple drugs were efficiently incorporated into ApDCs at predesigned positions. The ApDCs not only recognize target cancer cells specifically, but also release drugs in a photocontrollable manner. We demonstrated the potential of automated and modular ApDC technology for applications in targeted cancer therapy.

Related Papers

• → Designing Highly Specific Biosensing Surfaces Using Aptamer Monolayers on Gold(2006)103 cited
• → Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems(2015)86 cited
• → Synthesis and Properties of Cell-Targeted Zn(II)−Phthalocyanine−Peptide Conjugates(2007)84 cited
• → An aptamer cocktail-based electrochemical aptasensor for direct capture and rapid detection of tetracycline in honey(2019)40 cited
• → A versatile acid-labile linker for antibody–drug conjugates(2014)16 cited